1. Home
  2. NTST vs ELVN Comparison

NTST vs ELVN Comparison

Compare NTST & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$20.57

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$42.28

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
ELVN
Founded
2019
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NTST
ELVN
Price
$20.57
$42.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
5
Target Price
$22.02
$43.40
AVG Volume (30 Days)
1.2M
641.7K
Earning Date
04-20-2026
05-11-2026
Dividend Yield
4.28%
N/A
EPS Growth
150.00
3.17
EPS
0.06
N/A
Revenue
$195,006,000.00
N/A
Revenue This Year
$19.03
N/A
Revenue Next Year
$16.25
N/A
P/E Ratio
$345.08
N/A
Revenue Growth
19.79
N/A
52 Week Low
$15.37
$14.79
52 Week High
$21.30
$48.53

Technical Indicators

Market Signals
Indicator
NTST
ELVN
Relative Strength Index (RSI) 54.73 55.07
Support Level $19.98 $16.84
Resistance Level $21.24 $48.53
Average True Range (ATR) 0.33 2.29
MACD -0.02 -0.51
Stochastic Oscillator 66.67 44.44

Price Performance

Historical Comparison
NTST
ELVN

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: